| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |